Week held in Berlin, Germany, an informative session explored emerging approaches for the management of ulcerative colitis (UC), ranging from surgical interventions to updated treatment guidelines and ...

Interleukin-23 (IL-23) plays a pivotal role in the complex pathogenesis of both ulcerative colitis and Crohn's disease, making it a promising therapeutic target.1 Mirikizumab is a humanised IgG4 ...

Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the ...

The MarketWatch News Department was not involved in the creation of this content.-- Remsima(TM) IV (intravenous) liquid formulation, the world's first liquid formulation of IV inf ...

The following highlights spotlight the latest advances in gastroenterology, featuring studies and insights presented at this ...

Get tips from experts for UC-related bloating relief. Learn to better manage symptoms with medication, diet changes, and lifestyle adjustments.

Therapeutic drug monitoring is associated with better treatment durability among children with inflammatory bowel diseases.

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

Mirikizumab (Omvoh) is effective in inducing a clinical response in adults with moderate-to-severe ulcerative colitis and ...

Ulcerative colitis (UC) is one of the most common inflammatory bowel diseases, a lifelong condition that can cause chronic ...

A variant of the Aeromonas bacterium promoted colon inflammation in mice and was detected in stools and colon tissue from ...

Eli Lilly said federal regulators have approved of a single-injection, once-monthly maintenance regimen in the U.S. for its ulcerative colitis treatment Omvoh. The pharmaceutical company said Monday ...